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ABSTRACT
INTRODUCTION The present work examined the effect of passive exposure to 
electronic-cigarette (e-cigarette) emissions on respiratory mechanics and exhaled 
inflammatory biomarkers.
METHODS A cross-over experimental study was conducted with 40 healthy non-
smokers, 18–35 years old with normal physical examination and spirometry, with 
body mass index <30 kg/m2, who were exposed to e-cigarette emissions produced 
by a smoker, according to a standardized protocol based on two resistance settings, 
0.5 ohm and 1.5 ohm, for e-cigarette use. All participants underwent a 30-minute 
control (no emissions) and two experimental sessions (0.5 and 1.5 ohm exposure) 
in a 35 m3 room. The following Impulse Oscillometry (IOS) parameters were 
measured at pre and post sessions: impedance, resistance, reactance, resonant 
frequency (fres), frequency dependence of resistance (fdr=R5–R20), reactance area 
(AX), and fractional exhaled nitric oxide (FeNO). Differences between pre and post 
measurements were compared using t-tests and Wilcoxon signed rank tests, while 
analysis of variance (ANOVA) was used for comparisons between experimental 
sessions (registered under ClinicalTrials.gov ID: NCT03102684).
RESULTS IOS and FeNO parameters showed no significant changes during the control 
session. For IOS during the 1.5 ohm exposure session, fres increased significantly 
from 11.38 Hz at baseline to 12.16 Hz post exposure (p=0.047). FeNO decreased 
significantly from 24.16 ppb at baseline to 22.35 ppb post exposure in the 0.5 ohm 
session (p=0.006).
CONCLUSIONS A 30-minute passive exposure to e-cigarette emissions revealed 
immediate alterations in respiratory mechanics and exhaled biomarkers, expressed 
as increased fres and reduced FeNO.
INTRODUCTION
The adverse health effects of passive exposure to 
conventional cigarette smoke have been extensively 
studied and are well documented1. After 10 years of 
experience with electronic cigarettes (e-cigarettes)2 
it is known that its active use is associated with 
immediate adverse health effects3-9. However, limited 
studies have evaluated the potential impact on indoor 
air quality, as well as the health effects of exposure 
to second-hand aerosols from e-cigarettes6,9-16. 
Most studies that have examined passive exposure 
to e-cigarette emissions have several limitations, 
such as small sample sizes, use of smoking machines 
instead of humans, use of cell cultures or animal 
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models, varying e-cigarette devices, environment 
and methodologies, or lacked standardization of 
e-cigarette topography2,6,7,14. Only two studies have 
examined biomarkers in humans, such as blood 
count and cotinine in saliva and urine16,17, while only 
one study15 examined respiratory effects in terms of 
spirometry and FeNO.
E-cigarette liquid is a solution that usually contains 
nicotine, glycerol, propylene glycol and various 
flavour additives18. When thermally treated, it emits 
what is commonly referred to as a ‘vapour’, which 
is in fact a fine aerosol consisting of liquid and solid 
particles, dispersed in a gas18. Following inhalation 
using the e-cigarette, the aerosol is delivered into the 
user’s lungs, while during expiration the remaining 
aerosol is exhaled into the environment18, forming an 
unintentional pollution source of particulate matter 
(second-hand aerosol or SHA) to which bystanders 
are potentially exposed6,19.
A study by Schripp et al.10 concluded that the 
size distribution of aerosol particles is altered 
once it enters the user’s lungs, mainly due to their 
‘shrinking’ by evaporation of the liquid, finally 
leading to the exhalation of even smaller particles 
back into the environment10. These smaller particles 
(fine and ultrafine) released into the environment 
are a concern in terms of passive exposure given their 
ability to enter into the alveoli and ultimately into the 
circulatory system20.
In addition, Lerner et al.21 found that the 
e-cigarette aerosol modified the levels of oxidative 
stress and inflammatory biomarkers in human airway 
epithelial cells. They also reported un-vaporized 
e-cigarette liquid was associated with oxidative 
reactivity attributed to flavour additives; the sweet 
and fruit additives having been found to exhibit 
stronger oxidation than the tobacco flavours21.
Given the increasing popularity of e-cigarette use, 
limitations of existing studies and the lack of clinical 
studies on humans, especially with regard to lung 
function, our aim was to assess the effect of passive 
exposure to e-cigarette emissions on respiratory 
mechanics and exhaled biomarkers among young 
healthy adults. Furthermore, the study aimed to 
replicate realistic conditions of e-cigarette use and 
exposure. 
The current study was developed in the frame 
of the project Tackling second-hand tobacco smoke 
and e-cigarette emissions: Exposure assessment, novel 
interventions, impact on lung diseases and economic 
burden in diverse European populations (TackSHS), 
with the aim to improve our understanding of the 
possible health effects of second-hand exposure22.
METHODS
Study design
An experimental, cross-over, laboratory-based study 
was designed to measure passive exposure of non-
smokers to e-cigarette emissions. The experiment 
included three sessions on three different days: 
a control session with no emissions and two 
experimental sessions, conducted with a 2-day 
interval between them. Each participant underwent 
the sessions one at a time being exposed for 30 
minutes in a room measuring 35 m3. IOS and FeNO 
were measured in all sessions before and immediately 
after the 30-minute exposure.
For the control session, participants remained in 
the room for 30 minutes with the active e-cigarette 
user present without activating the e-cigarette. 
During the experimental sessions, an experienced 
e-cigarette user familiar with a new-generation 
e-cigarette device, produced aerosol emissions, 
according to a standardized protocol for settings, 
topography and e-cigarette liquid. According to 
manufacturer’s recommendations, the e-cigarette 
with the 0.5 ohm resistance was set at 22.5 watts 
(0.5 ohm session), while the e-cigarette with the 
1.5 ohm resistance was set at 14.0 watts (1.5 ohm 
session). Topography for smoking was 4-second 
puffs with 20-30 second inter-puff intervals using 
the same e-cigarette device for all sessions23-25. The 
same tobacco flavored e-cigarette liquid was used 
for exposure sessions, containing propylene glycol 
46.13% w/v, glycerol 34.3% w/v, nicotine 1.18% w/v 
and tobacco essence (<5% w/v)26.
Participants
Volunteer participants were recruited by word-
of-mouth and posted invitations at universities 
in Athens, Greece, from March to July 2017. A 
total of 40 non-smokers (20 male and 20 female) 
aged 18–35 years, healthy (with non-significant 
medical history, normal physical examination and 
flow-volume loop within predicted normal limits 
according to the American Thoracic Society/
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European Respiratory Society [ATS/ERS] Task 
Force 2005) and body mass index (BMI) <30 kg/
m2, were included in the current study. Exclusion 
criteria included current (daily or occasional) 
smokers, former smokers (having quit smoking less 
than 1 year prior to the study), age under 18 or over 
35 year, BMI >30 kg/m2, pregnancy or lactation, 
any ongoing or recent illness or infection (<4 weeks 
prior to study), acute or chronic conditions, and any 
use of medication (<2 weeks prior to study). All 
participants were instructed to fast for two hours 
prior to each session27. 
Ethical and legal aspects
Volunteer participants were informed of the scope 
of the study and their right to access and withdraw 
at any time. Each participant gave their written 
informed consent prior to beginning the study. Ethics 
approval was granted from the Ethics Committee 
of the School of Medicine, National Kapodistrian 
University of Athens (protocol: 1617006410), and 
the study was registered in clinicaltrials.gov (ID 
NCT03102684).
Measurement of respiratory parameters
Flow-volume loop and exhaled carbon monoxide 
(eCO)
Baseline flow volume was performed prior to 
study sessions as a prerequisite for inclusion. The 
maneuver was performed in a sitting position with 
a nose-clip applied using a Jaeger MasterScreen 
Spirometry system (Franklin Lake, NJ, USA). Forced 
vital capacity (FVC), forced expiratory volume in the 
first second (FEV
1
), Tiffeneau Index (FEV
1
/FVC%), 
peak expiratory flow (PEF) and mid-expiratory 
flows (FEF at 25%, 50% and 75% of exhaled FVC) 
were measured along with their predictive values 
calculated by computer software.
Using a Bedfont® Scientific Ltd. Micro+™ 
Smokerlyzer® (Harrietsham, Maidstone, Kent) 
calibrated according to manufacturer’s guidelines, 
eCO was measured prior to each session with 
inclusion <7 ppm28 to ensure non-smoking status and 
absence of exposure prior to beginning each session. 
With a nose-clip applied, participants were instructed 
to inhale and hold their breath for approximately 
15 seconds and then exhale into the mouthpiece for 
approximately 10 seconds28.
Impulse oscillometry
Impedance at 5 Hz (Z5), resistance at 5, 10 and 20 Hz 
(R5, R10 and R20), reactance at 5 Hz (X5), resonant 
frequency (fres), frequency dependence of resistance 
(fdr) and reactance area (AX) were measured using 
a Viasys Jaeger Masterscreen IOS system (Franklin 
Lake, NJ, USA). In an upright sitting position with a 
nose-clip applied and cheeks lightly supported by the 
participant’s hands, the participant was instructed to 
breathe normally and performed three reproducible 
trials with intra-assay coefficient of variation (CV) 
<10%29.
Fractional exhaled nitric oxide (FeNO)
U s i n g  E c o  M e d i c s  A G  C L D  8 8  S e r i e s 
chemiluminescence analyzer (Durnten, Switzerland) 
equipped with a Spiroware 3.0 software program, 
three reproducible measurements (with intra-assay 
CV<10%) were performed in a sitting position with 
a nose-clip applied. Participants were instructed 
to deeply inhale through a filtered mouthpiece 
and consecutively exhale at a mouth flow rate of 
approximately 50 mL/s for 10 seconds.
All procedures were performed according to ATS/
ERS guidelines27,29,30.
Statistical analysis
Demographics and inclusion criteria for the whole 
sample of 40 young non-smokers were presented 
as mean and standard deviation (SD). IOS and 
FeNO measurements were also presented as mean 
and SD. The differences between pre and post 
IOS and FeNO measurements were evaluated for 
significance using Wilcoxon signed-rank test and 
student t-tests for paired data. Analysis of variance 
(ANOVA) for repeated measurements was used to 
assess differences between exposures accounting 
for differences between pre and post values. To 
account for multiple comparisons, a Tukey correction 
was used. All tests were two-tailed and statistical 
significance was set at 5% (p<0.05). Data were 
analysed using Stata™ (Version 15.0 SE, Stata 
Corporation, College Station, TX 77845, USA).
RESULTS
Demographics and flow-volume loop
Participants had a mean age of 24.6 years, weight 
of 71.4 kg, height of 174.1cm and BMI of 23.4 kg/
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m2 (Table 1). Baseline flow-volume loops were 
within normal limits (Table 1). All exhaled CO 
measurements were <7 ppm prior to starting each 
session with an average of 2.1 ppm in all sessions 
ranging from 1 to 5 ppm. Five of the forty participants 
were former smokers, with three of them reporting 
having smoked for under 5 years and the other two 
for 7–8 years.
IOS and FeNO
As shown in Table 2, there was a significant increase 
in fres in the 1.5 ohm session and a significant 
decrease in FeNO in the 0.5 ohm session, pre 
to post exposure to SHA from e-cigarettes. Mean 
value for Z5 in the control session was 0.40 kPa/L/s 
pre and 0.41 kPa/L/s post exposure, indicating no 
significant change. In both experimental sessions, 
Z5 did not change significantly from pre to post 
exposure.
In the control session, R5 did not change 
significantly from pre to post exposure (p=0.472). 
In the 0.5 ohm session, mean pre and post 
measurements did not change from 0.39 kPa/L/s. 
In the 1.5 ohm session, R5 showed a post exposure 
decrease trend that was not significant, with mean 
values of 0.39 pre to 0.38 kPa/L/s post exposure 
(Table 2).
In both control and 1.5 ohm sessions, R10 and 
R20 did not change from pre to post (mean 0.34 
kPa/L/s). During the 0.5 ohm session, R10 remained 
Table 2. Results of Impulse Oscillometry (IOS) and fractional exhaled nitric oxide (FeNO) pre and post all 
exposure sessions in 40 participants, Athens 2017.
Mean (SD)
Age (years) 24.6 (4.3)
Weight (kg) 71.4 (15.4)
Height (cm) 174.1 (10.5)
BMI (kg/m2) 23.4 (3.8)
eCO (ppm)
  control 2.1 (1.0)
  0.5 ohm 2.2 (0.7)
  1.5 ohm 2.0 (0.6)
Flow volume % Predicted (SD)
  FVC(L) 4.65 (1.18) 100.5 (10.3)
  FEV1(L) 3.86 (0.91) 97.8 (10.3)
  FEV1/FVC(%) na 83.7 (6.2)
  FEF25/75 (L/s) 4.09 (1.20) 89.1 (21.1)
  FEF25%(L/s) 7.74 (1.94) 104.1 (14.7)
  FEF50%(L/s) 5.15 (1.50) 99.7 (24.7)
  FEF75%(L/s) 2.21 (0.76) 89.7 (25.7)
  PEF(L/s) 8.29 (2.01) 95.6 (12.3)
Table 1. Demographics, exhaled carbon monoxide (eCO) 
prior to sessions and baseline Spirometry among the 40 
participants ( 20 men and 20 women), Athens 2017.
BMI: Body mass index; SD: standard deviation; FVC: forced vital capacity; FEV1: forced 
expiratory volume in the first second; Tiffeneau Index: FEV1/FVC%; Mid-expiratory 
flows: FEF at 25%, 50% and 75% of exhaled FVC; PEF: peak expiratory flow; na: not 
applicable. 
Session Pre SD Post SD Diff. p
Z5 (kPa/L/s) control 0.40 0.11 0.41 0.11 0.01 0.302t
0.5 ohm 0.41 0.12 0.41 0.12 0.00 0.661
1.5 ohm 0.41 0.13 0.40 0.12 -0.01 0.930
R5 (kPa/L/s) control 0.38 0.10 0.38 0.11 0.00 0.472t
0.5 ohm 0.39 0.11 0.39 0.12 0.00 0.638
1.5 ohm 0.39 0.13 0.38 0.12 -0.01 0.721
R10 (kPa/L/s) control 0.34 0.09 0.34 0.09 0.00 0.291t
0.5 ohm 0.35 0.10 0.35 0.10 0.00 0.540
1.5 ohm 0.34 0.11 0.34 0.10 0.00 0.377
R20 (kPa/L/s) control 0.34 0.08 0.34 0.09 0.00 0.580t
0.5 ohm 0.34 0.09 0.35 0.09 0.01 0.373t
1.5 ohm 0.34 0.09 0.34 0.09 0.00 0.571
Mean R5-R20 control 0.36 0.09 0.36 0.09 0.00 0.495t
(kPa/L/s) 0.5 ohm 0.36 0.10 0.37 0.11 0.01 0.340
1.5 ohm 0.36 0.11 0.36 0.10 0.00 0.584
X5 (kPa/L/s) control -0.11 0.04 -0.11 0.04 0.00 0.819t
0.5 ohm -0.12 0.04 -0.14 0.13 -0.02 0.906
1.5 ohm -0.12 0.04 -0.11 0.03 0.01 0.286
Continued
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at 0.35 kPa/L/s pre and post exposure, while R20 
increased non-significantly from 0.34 to 0.35 kPa/
L/s (Table 2). In both control and 1.5 ohm session, 
mean R5–R20 did not change from 0.36 kPa/L/s. In 
the 0.5 ohm session, mean R5–R20 exhibited a non-
significant increase from 0.36 pre to 0.37 kPa/L/s 
post exposure (Table 2). As shown in Table 2, X5 did 
not change in the control session with mean -0.11 
kPa/L/s. In the 0.5 ohm session, X5 decreased from 
-0.12 pre to -0.14 kPa/L/s post exposure, while in 
the 1.5 ohm session it increased from -0.12 to -0.11 
kPa/L/s. 
In the control and 0.5 ohm sessions, fres did 
not change significantly (p=0.141 and p=0.066, 
respectively). In the 1.5 ohm session, fres showed 
a significant increase of 6.9% (mean 11.38 Hz pre 
and 12.16 Hz post exposure, p=0.047) (Table 2). Pre 
and post changes differed significantly between the 
experimental sessions (p=0.030).
AX did not change significantly from pre to 
post exposure for all three sessions with mean 
measurements 0.33 pre to 0.34 kPa/L/s post 
exposure in the control session (p=0.440), 0.36 
to 0.34 kPa/L/s in the 0.5 ohm session (p=0.224), 
and 0.38 to 0.36 kPa/L/s in the 1.5 ohm session 
(p=0.247) (Table 2).
In the 0.5 ohm session, FeNO exhibited a 
significant decrease of 7.5% (mean 24.16 ppb pre 
and 22.35 ppb post exposure, p=0.006), whereas in 
the control and 1.5 ohm sessions it did not change 
significantly (Table 2).
DISCUSSION
The current study found that passive exposure to 
SHA produced by e-cigarette users showed minor 
alterations in respiratory mechanics and exhaled 
NO of the exposed participants, while the role 
of the resistance/power settings was found to be 
inconclusive. 
Respiratory mechanics were evaluated by IOS, 
as it only requires quiet breathing and captures 
subtle alterations of lung mechanics even when 
spirometry is still normal31,32. IOS captures the non-
uniformities in airflow distribution, considered an 
early manifestation of small-airways disease and so 
represents an ideal screening tool33. The current 
study found a significant increase in fres after the 
1.5 ohm session. It is known that fres decreases 
with age and increases for both restrictive and 
obstructive disorders33,34. The obstructive airway 
pattern, expressed with increased fres, AX, R5 and 
R20, is evident in asthma where fres, R5 and R20 
increase with broncho-provocation and decrease 
with broncho-dilation34. The same combination of 
changes (increased fres, R5 and R20) are observed 
in the case of peripheral-airways obstructive 
pattern, as in the study of Lappas et al.4, where IOS 
measurements pre and post active e-cigarette use 
revealed a peripheral-airways obstruction pattern. 
The alteration of fres found in the present study was 
isolated and did not fall into a specific diagnostic 
(restrictive or obstructive) pattern. However, it 
expresses the inhomogeneous airflow distribution33, 
and hence the increased fres that was found could be 
interpreted as the footprint of the immediate likely 
irritative effect that SHA from e-cigarettes exerted on 
the airways.
The trend of FeNO reduction found post exposure 
was significant in the 0.5 ohm session. This finding 
is similar to previous studies that found FeNO 
SD: standard deviation; p-values result of Wilcoxon signed rank test unless indicated by t-results of t-test; Diff.: Difference between post and pre exposure. 
Continued
Session Pre SD Post SD Diff. p
fres (Hz) control 11.15 3.24 11.33 3.30 0.18 0.141
0.5 ohm 11.70 3.27 11.23 2.82 -0.47 0.066
1.5 ohm 11.38 3.66 12.16 4.07 0.78 0.047
AX (kPa/L) control 0.33 0.26 0.34 0.28 0.01 0.440
0.5 ohm 0.36 0.26 0.34 0.25 -0.02 0.224
1.5 ohm 0.38 0.46 0.36 0.26 -0.02 0.247
FeNO (ppb) control 26.45 0.11 25.00 0.11 -1.45 0.070
0.5 ohm 24.16 0.12 22.35 0.12 -1.81 0.006
1.5 ohm 24.35 0.13 23.44 0.12 -0.91 0.368
Table 2.
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reduction after exposure to active smoking of 
combustible cigarettes, cigars and e-cigarettes3,4,35,36, 
as well as after passive exposure to second-hand 
smoke37. Furthermore, the only study15 that examined 
FeNO post SHA exposure, although having several 
methodological differences and limitations (including 
small sample size, no reported number of efforts or 
coefficient of variation in FeNO measurements), 
and most notably the use of a smoking machine, also 
found a similar trend in FeNO reduction immediately 
post exposure, however non-significant. It is known 
that cigarette smoke results in FeNO reduction by 
activating the down-regulation of NO synthases 
(inducible and endothelial isoenzymes)38 through 
the nitric oxide it contains39. It is also known that the 
e-cigarette functions by heating the e-cigarette liquid 
to over >300 degrees Celsius19 and that nicotine, when 
heated to >247 degrees Celsius, decomposes into nitric 
oxides and carbon monoxide40. Therefore, it is possible 
that FeNO reduction observed in the current study 
resulted from the activation of the down-regulation 
mechanism due to the NO produced from the thermal 
decomposition of nicotine during e-cigarette use.
Fo l lowing  the  recommendat ions  o f  the 
e-cigarette manufacturer, a higher power setting 
was combined with the lower resistance of the 0.5 
ohm session. Kosmider et al.41 found that setting 
the e-cigarette to higher power (watts) released 
significantly higher levels of carbonyls, such as 
formaldehyde, acetaldehyde and acetone than lower 
power settings. In addition, this effect was more 
pronounced in propylene glycol based e-cigarette 
liquids41. Sosnowski et al.19 showed that the 
aerodynamic resistance of e-cigarettes is 10 times 
higher than for dry-powder inhalers and requires a 
significantly higher physical effort for inhalation than 
conventional cigarettes. Therefore, it is possible that 
regardless of the standardized breathing pattern of 
the e-cigarette user, due to the different resistance/
power combinations, the SHA produced in each 
experimental session was slightly different, resulting 
in the different effects observed in FeNO. 
Building on previous research on the health effects 
of active e-cigarette use, the current findings provide 
evidence that 30 minutes of passive exposure to 
e-cigarette emissions result in indications of small-
airways irritation, reflected by increased fres and a 
mild inflammatory reaction of the airways expressed 
by reduced FeNO.
The current study examined short-term exposure 
and so conclusions on the potential long-term effects 
of SHA cannot be made. In terms of developing a 
scientific research base for evidence-based policy, 
further studies are needed to examine the possible 
impact of longer exposure duration and the potential 
additive effect of repeated exposure. 
Strengths and limitations
The current study had several strengths, including 
use of a novel e-cigarette device, a cross-over trial 
study design, a statistically representative sample size 
of young healthy adults and standardized topography 
for e-cigarette use by an experienced smoker. 
In addition, all measurements were performed 
according to ATS/ERS guidelines. 
As the aim of the current study was to explore 
the passive exposure among young healthy adults, 
it did not examine the possible effect on patients 
with respiratory or other medical conditions. Blind 
control was not possible since participants were 
able to visually detect the difference in exposure 
conditions (presence of aerosol cloud), therefore the 
possible psychological effect of this knowledge was 
not accounted for.
CONCLUSIONS
The current study provides evidence that exposure 
to SHA from e-cigarettes has immediate effects on 
respiratory mechanics and exhaled inflammatory 
biomarkers. These findings add to the growing 
amount of evidence on the immediate health effects 
of e-cigarettes. Whereas the clinical implications 
need further assessment, these findings should be 
taken into account in global policies regarding the 
regulation of e-cigarette use in public places and in 
assessments of the effects of SHA on the health of 
bystanders.
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